Virupaksha Organics Ltd.: A Leading Producer of Fexofenadine HCl
Virupaksha Organics Ltd. has solidified its position as a key player in the global pharmaceutical industry, particularly in the production of Fexofenadine Hydrochloride (HCl), a widely used antihistamine for treating allergy symptoms. With cutting-edge manufacturing facilities in Telangana, India, Virupaksha adheres to the highest international standards of quality and compliance, ensuring the production of top-quality Fexofenadine HCl for both domestic and international markets.
Virupaksha’s facilities are certified by WHO-GMP, ISO 9001, and ISO 14001, which attests to the company’s commitment to maintaining rigorous quality control and environmental management. The company’s production capabilities and advanced R&D enable it to deliver cost-effective, high-purity APIs that meet the growing global demand for Fexofenadine HCl.
With its focus on innovation, sustainability, and customer satisfaction, Virupaksha Organics continues to be a trusted partner for pharmaceutical companies worldwide. Its strategic approach to producing APIs like Fexofenadine HCl positions the company as a leader in the antihistamine market, contributing to improved healthcare outcomes for millions of patients globally.
As the demand for allergy medications rises, Virupaksha Organics remains at the forefront of API production, demonstrating excellence in pharmaceutical manufacturing and reinforcing its status as a premier producer of Fexofenadine HCl.
Other Latest News
- The growing role of CDMOs in the circular economy October 15, 2024 12:37 pm Pharmaceutical Technology Sustainability in the 21st century is an essential component of business operations. With regard to environmental stewardship, new regulations in many countries are forcing companies to be more transparent about and accountable for their greenhouse gas ( …
- Enteric Empty Capsules Market is Expected to Rise to US$ 5.21 Billion with a CAGR 6.8% From 2024-2032 October 15, 2024 12:35 pm EIN Presswire Growing demand for earmarked drug conveyance systems is driving the market demand. NEW YORK CITY, NY, UNITED STATES, October 15, 2024 /EINPresswire.com/ — Our enteric empty capsules market report has been prepared using advanced methodologies …
- Nifty to trade negatively until 25,300 not reclaimed, says Ajit Mishra of Religare Broking October 15, 2024 11:20 am Financial Express By Ajit Mishra The markets ended the week marginally lower, marking a pause after a sharp decline. The week started on a downbeat note due to continued selling pressure from foreign investors, but selective strength in heavyweight stocks helped limit the …
- LEO launches chronic hand eczema drug in its first market October 15, 2024 11:17 am pharmaphorum Germany has become the debut market for LEO Pharma's Anzupgo, the first topical treatment specifically approved for chronic hand eczema (CHE). The launch of pan-JAK inhibitor Anzupgo (delgocitinib) comes after the European Commission approved the drug …
- Delhi drug haul: How cocaine recovery unveiled cartel with global links to Dubai, UK, South America? October 15, 2024 11:08 am India TV News The Special Cell of Delhi Police seized over 560 kg of cocaine and 40 kg of marijuana with an estimated worth of Rs 5,620 crore from a godown in South Delhi's Mahipalpur on October 2. It was the biggest drug recovery in India so far. During the drug …
- Buy the dips or brace for more corrections? HDFC Securities’ Deepak Jasani weighs in October 15, 2024 10:47 am Business Today After a volatile start in October due to geopolitical concerns and India Inc's Q2 earnings, Indian stock market appears to be back on track. Business Today interacted with Deepak Jasani, Head of Retail Research at HDFC Securities, where he shared his …
- Lupin launches first generic formulation of Abbie’s drug to treat eye disorder October 15, 2024 10:31 am Financial Express Global pharma major Lupin Limited on Tuesday announced the launch of the first generic version of Pred Forte (Prednisolone Acetate) Ophthalmic Suspension USP, 1% in the United States. According to the company’s press statement, being the first generic to …
- Glycolic Acid Market to Surpass USD 782.9 Million by 2034, Driven by Growing Demand in Skincare and Industrial Applications | Future Market Insights, Inc. October 15, 2024 10:30 am EIN Presswire NEWARK, Del, Oct. 15, 2024 (GLOBE NEWSWIRE) — The Glycolic Acid Market is poised for steady growth in the coming decade, primarily driven by rising demand from the cosmetic and skincare sectors. Glycolic acid, a popular alpha hydroxy acid (AHA), is widely …
- Investment firm Multiples adds credit strategy unit, hires ex-Deutsche man as MD October 15, 2024 10:21 am Mint Bengaluru: Multiples Alternate Asset Management has added a new credit strategy division and appointed former Deutsche Bank executive Rahul Chawla as its managing director to oversee the unit, the investment firm said in a statement on Tuesday. Several …
- Keir Starmer tells regulators to chill as Microsoft exec takes wheel of advisory council October 15, 2024 10:13 am The Register UK prime minister Keir Starmer promised to make the nation's competition regulator more inclined toward economic growth the day after a Microsoft executive was appointed chair of the government's Industrial Strategy Advisory Council. At the UK' …
- How a CDMO is staying on top of API and drug product manufacturing trends October 15, 2024 10:11 am Outsourcing-Pharma Outsourcing Pharma caught up with experts from the global CDMO, CordenPharma, to learn how they maintain their competitive edge. Brittany Hayes, Global Platform Director for Highly Potent & Oncology, and Ilia Freifeld, Global Platform Director for …
- Sensex slides 232 pts; Eurpoean mrkt advance October 15, 2024 8:50 am Business Standard The key equity indices traded with modest losses in afternoon trade. The Nifty slipped below the 25,050 mark after hitting the days high of 25,212.05 in early trade. Metal, auto and pharma shares declined while media, realty and FMCG stocks advanced. At 13 …
- Oyo parent Oravel Stays likely to raise $200 million at 2x valuation of $4.5-5 billion: Report October 15, 2024 7:58 am India Blooms New Delhi/IBNS: Oravel Stays, the parent company of the global travel and hospitality firm Oyo, is reportedly in discussions to raise $200 million through a primary funding round, according to a report by Business Standard. The company is aiming for a …
- Mubadala’s KELIX bio buys four GlobalOne Healthcare pharma assets October 15, 2024 7:45 am Gulf Business Image credit: Emirates News Agency Mubadala-backed KELIX bio has acquired a 100 per cent stake in four of GlobalOne Healthcare Holding’s pharma assets, which include Bioventure, Bioventure Healthcare, Gulf Inject and Wellpharma. The acquisition marks a …
- FPIs dump Indian stocks for 11th straight session, withdraw ₹73,000 crore October 15, 2024 7:43 am Mint The selling streak by foreign portfolio investors (FPIs) continues to grow, with another outflow of ₹3,731.60 crore from Indian stocks recorded in Monday's trading session. This marks the 11th consecutive day of selling, highlighting a sustained trend …
- Obesity Drug Wegovy Launched in Korea Today at 370,000 Won October 15, 2024 6:14 am Business Korea Korean Novo Nordisk Pharmaceuticals is set to launch the obesity treatment drug Wegovy on Oct. 15, marking a significant milestone 18 months after receiving approval from the Ministry of Food and Drug Safety (MFDS) in April last year. The drug, developed …
- Lonza Portsmouth becomes 5th New Hampshire Life Sciences founding member October 15, 2024 5:14 am Manchester Ink Link – New Hampshire Global pharma and biotech company Lonza Portsmouth recently became the fifth founding member of New Hampshire Life Sciences, the state’s new life sciences industry association. Lonza Portsmouth photo BEDFORD, NH – Biotech company Lonza Portsmouth recently …
- Forbion raises in excess of €2 billion for two new funds October 15, 2024 5:00 am EIN Presswire Forbion’s largest fundraising to date, with Forbion’s Growth Opportunities Fund III raising €1.2 billion and Forbion Ventures Fund VII raising €890 million Assets under management now at €5 billion Fundraising follows strong performance, with six exits of …
- ASX Small Cap Lunch Wrap: Banks and Resources have pushed ASX 200 to another record high October 15, 2024 4:00 am Stockhead Local markets have opened higher this morning, thanks to a decent lead-in from Wall Street overnight – and that saw the ASX 200 bolt to a new record high almost as soon as the doors were open for today’s session. There’s been a run on Banks, InfoTech and …
- Stocks in news: RIL, HCL Tech, Garuda Construction, JSW Infra, Angel One, IOB, Zydus Life & CESC October 15, 2024 3:15 am Business Today Indian benchmark indices kicked off the week on a strong note and settled higher on Monday despite muted global cues. BSE Sensex jumped 591.69 points or 0.73 per cent, to end at 81,973.05. NSE's Nifty50 rallied 163.70 points, or 0.66 per cent, to close …
- Nadda: 95% of drug regulatory processes in India digitised October 15, 2024 2:20 am ET Healthworld New Delhi : Union health minister J P Nadda on Monday said that more than 95 per cent drug regulatory processes in the country have been digitised, bringing transparency and increasing trust among stakeholders. Nadda also pointed out that to make the drug …
- Global pharma firms to increase investments in mainland China October 15, 2024 1:47 am Thailand Business News Bayer Co.Lab will enhance biotech partnerships in Mainland China, supporting local drug discovery and R&D. Government efforts and multinational investments are poised to boost the pharmaceutical sector’s growth. Bayer’s new Shanghai incubator will …
- Health Check: It’s all in the vibe as Invion and Wellness Life shrink to share greatness October 15, 2024 1:46 am Stockhead Invion Therapeutics is the latest biotech to consolidate its ‘penny dreadful’ shares Artrya is confident of US approval for its algorithmic heart plaque detection tool Pitt Street Research says Island Pharmaceuticals should be worth up to 115% more …
- Global Antipsychotic Drugs Market Size, Share, And Growth Analysis For 2024-2033 October 15, 2024 1:30 am EIN Presswire The Business Research Company’s Antipsychotic Drugs Global Market Report 2024 – Market Size, Trends, And Forecast 2024-2033 LONDON, GREATER LONDON, UNITED KINGDOM, October 15, 2024 /EINPresswire.com/ — The antipsychotic drugs market has …
- Lundbeck’s Neuro-Rare Pipeline Lands Cornerstone Drug via $2.6B Longboard Pharma Acquisition October 15, 2024 12:38 am MedCity News Neuroscience drug developer Lundbeck is expanding its scope to epilepsy via the $2.6 billion acquisition of Longboard Pharmaceuticals, a company whose lead asset is in late-stage clinical development for a rare, inherited seizure disorder that has few …